- Since July 2023, three anti-amyloid medications have been FDA-approved for the treatment of Alzheimer’s disease with more in development.
- A potential and serious side effect of anti-amyloid medications is amyloid-related imaging abnormalities (ARIA), where swelling or small bleeding areas of the brain occur.
- People who carry the apolipoprotein E-E4 gene (APOE-e4) are at a higher risk of developing ARIA when taking anti-amyloid drugs.
- Researchers have developed a new test to help determine…
Read the full article here